With what we know about the timeline for the Lovenox trial, do you think NVS is giving serious consideration to acquiring MNTA sooner than later? It seems like if they wait too long, a nice stream of good news out of Momenta is going to make them much pricier. Or do you think the Alcon acquisition has tempered their M&A fever in the short term?
Market Data 
Markets 
AI
